Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
Prescient Therapeutics, Ltd.
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
Fondazione Italiana Linfomi - ETS
Fondazione Italiana Linfomi - ETS
Institute of Hematology & Blood Diseases Hospital, China
Soligenix
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
Mayo Clinic
Kyowa Kirin Co., Ltd.
Columbia University
SciTech Development, Inc.
City of Hope Medical Center
University of Alabama at Birmingham
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University